{"@id":"https://bioecon.ru/technology/viral-vectored-neoantigen-vaccines/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://bioecon.ru/technology/viral-vectored-neoantigen-vaccines/","json":"https://bioecon.ru/api/v1/technology/viral-vectored-neoantigen-vaccines/index.json"},"id":"viral-vectored-neoantigen-vaccines","industries":["pharma","biomanufacturing"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/genscript-probio-genscript/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/vaksindo-animal-health/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/vaxxinova-norway/","https://bioecon.ru/companies/ridgeway-biologicals/","https://bioecon.ru/companies/gsk/"]},"maturity":7,"name":"Вирусные векторные вакцины с персонализированными неоантигенами","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Компьютерное предсказание неоантигенов"},{"n":2,"title":"Дизайн полиэпитопной кассеты"},{"n":3,"title":"Сборка аденовирусного вектора"},{"n":4,"title":"Иммунизация 'прайм-буст'"}],"summary":"Гетерологичные вакцины 'прайм-буст' на основе аденовирусов шимпанзе (ChAd) и вируса осповакцины (MVA), кодирующие десятки персонализированных неоантигенов опухоли для индукции мощного Т-клеточного ответа.","url":"/technology/viral-vectored-neoantigen-vaccines/","verified":"2026-11-22"}